SFPT Session 3 - Methodology in clinical research and pharmacoepidemiology

17:00 • INT3 • From prediction to prescription > G. Gaël VAROQUAUX 17:30 • 172 • Causal Language used in Titles and Abstracts of Target Trial Emulation Studies > C. Christos TSAMASIOTIS 17:40 • 232 • Prior probability of treatment efficacy and reliability of clinical trial results: lessons from the COVID-19 pandemic > J-C. Jean-Christophe Lega 17:50 • 259 • Estimating the environmental impact of clinical research : carbon footprint and major hotspots of two academic clinical trials > C. Claire Fougerou-Leurent 18:00 • 352 • Constructing an external control arm using the French REALYSA cohort to replicate outcomes of a randomized trial arm in advanced Hodgkin lymphoma. > O. Olivia Febvey-Combes 18:10 • 61 • Benefit-risk balance assessment based on single-arm clinical trials in the context of Accelerated Approvals and Conditional Marketing Authorizations in oncology and malignant hematology: A Systematic Review > M. Marie Sicard 18:20 • 94 • Anatomy of 237 zombie randomized controlled trials threatening evidence-based medicine: 94% significant results from 100% fraud > T. Tala JAJIEH